Product Images Amoxicillin

This is a description of a medication with the active ingredient being 75mg of Amoxicillin, with a quantity of 20 tablets per package. Patients are advised to take the medication as prescribed and to call their doctor for medical advice about potential side effects. The Expiry date mentioned is 08/2023, and there is additional information about the Lot number of the medication.*

This is a table showing the recommended dosage for Amoxicillin antibiotics for treating infections in both adults and children over 3 months of age. The table displays recommended doses for ear, nose and throat infections, skin and skin structure infections, genitourinary tract infections, lower respiratory tract infections, and uncomplicated anogenital and urethral infections. The recommended dosages vary for moderate, severe and acute cases of infections, and the recommended dosages are different for children and adults. The table also includes a note cautioning against using a specific regimen for children under 2 years of age.*

This is a chemical formula representing a molecule with a carboxylic acid functional group. It consists of a hydroxyl group (HO-) and a carboxyl group (COOH) attached to a carbon atom. Carboxylic acids are commonly used in food flavorings, fragrances, and pharmaceuticals.*

Table 3 shows the mean Pharmacokinetic Parameters of Amoxicillin with a dose of 400 mg/5 mL suspension and 400 mg chewable tablets in healthy adults. The results suggest that the AUC and Cha values of Amoxicillin for the 400 mg chewable tablet are higher than the 400 mg/5 mL suspension dose. The medication was administered at the start of a light meal and peak concentrations were achieved approximately one hour after the dose.*

This is a list of different types of bacteria categorized into Gram-positive and Gram-negative. The Gram-positive category includes: Enterococcus faecalis, Staphylococcus spp., Streptococcus pneumoniae, and alpha and beta-hemolytic streptococci. The Gram-negative category includes: Escherichia coli, Haemophilus influenzae, Neisseria gonorrhoeae, Proteus mirabilis, and Helicobacter pylori.*

This is a table showing the H. pylori eradication rates of triple therapy including amoxicillin. The table displays two studies evaluating the therapy, both with evaluable and intent-to-treat analysis. The patients included in the analysis had confirmed H. pylori infection at baseline and a confirmed duodenal ulcer (active or within 1 year). If patients dropped out due to adverse events related to the study drug, they were included in the analysis as therapy failures.*